Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 41

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02228031Early Phase 1Completed
Oxytocin, Emotions and Mirror Neurons
Expressed EmotionSocial Cognition
PrincipalinvestigatorStart date: 2014-10-01
NCT00056498Phase 4Completed
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
Schizophrenia
PrincipalinvestigatorStart date: 2001-12-01
NCT00547118Phase 2Terminated
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
HypertensionObesitySchizoaffective Disorder+2 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02228031Early Phase 1PrincipalInvestigator

Oxytocin, Emotions and Mirror Neurons

Expressed EmotionSocial Cognition
Completed
NCT00056498Phase 4PrincipalInvestigator

Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine

Schizophrenia
Completed
NCT00547118Phase 2PrincipalInvestigator

The Effects of Rimonabant, on Weight and Metabolic Risk Factors

HypertensionObesitySchizoaffective Disorder+2 more
Terminated

All 3 trials loaded